Intelligent Insulin Management Platform
Legal Citation
Summary of the Inventive Concept
An innovative system integrating AI, IoT, blockchain, and new materials to optimize insulin administration and improve patient outcomes
Background and Problem Solved
The original patent's insulin management system, while effective, has limitations in data accuracy, security, and patient engagement. The new inventive concept addresses these limitations by incorporating cutting-edge technologies to create a more comprehensive and personalized insulin management platform.
Detailed Description of the Inventive Concept
The Intelligent Insulin Management Platform combines a blockchain-based patient data management module with an AI-driven clinical decision support system, IoT-enabled continuous glucose monitoring, and a cloud-based data analytics platform. This integrated system enables real-time monitoring, personalized insulin dosing, and secure data storage. The platform also features a wearable device with integrated IoT sensors, a natural language processing (NLP) module, and a mobile app for patient engagement.
Novelty and Inventive Step
The new inventive concept's integration of AI, IoT, blockchain, and new materials with the original insulin management system provides a non-obvious and novel approach to optimizing insulin administration. The inventive step lies in the synergistic combination of these distinct technologies to create a more powerful and effective system.
Alternative Embodiments and Variations
Alternative embodiments of the Intelligent Insulin Management Platform could include the use of different AI algorithms, various IoT sensor configurations, or alternative blockchain architectures. Additionally, the platform could be adapted for use in different healthcare settings or for managing other chronic conditions.
Potential Commercial Applications and Market
The Intelligent Insulin Management Platform has significant commercial potential in the healthcare industry, particularly in the areas of diabetes management and personalized medicine. The platform's ability to improve patient outcomes, reduce healthcare costs, and enhance patient engagement makes it an attractive solution for healthcare providers, pharmaceutical companies, and medical device manufacturers.
Section 103 Obviousness Analysis (PHOSITA)
Field of Art
Medical informatics and digital health technologies focused on insulin management, diabetes care, and patient monitoring systems
Person of Ordinary Skill (PHOSITA) Profile
A skilled professional with expertise in biomedical engineering, computer science, and healthcare information systems, possessing knowledge of medical data processing, AI applications in clinical decision support, and IoT-enabled medical monitoring technologies
Obviousness Rationale
A PHOSITA would recognize that the PTD's integration of blockchain, AI, and IoT technologies represents a predictable extension of the source patent's core insulin management methodology. The fundamental goal of improving insulin administration through digital technologies remains consistent, with the PTD merely applying known technological approaches to enhance the original system's capabilities. The combination of existing technologies to solve a known problem in medical data management would be considered an obvious iterative improvement by a skilled practitioner.
Obvious Combinations & Variations
Original Patent Information
| Patent Number | US 11,857,314 |
|---|---|
| Title | Insulin management |
| Assignee(s) | Aseko, Inc. |